121 related articles for article (PubMed ID: 24842443)
21. Safety and effectiveness of the association ezetimibe-statin (E-S) versus high dose rosuvastatin after acute coronary syndrome: the SAFE-ES study.
Deharo P; Pankert M; Quilici J; Grosdidier C; Verdier V; Bonnet G; Morange P; Alessi MC; Bonnet JL; Cuisset T
Ann Cardiol Angeiol (Paris); 2014 Sep; 63(4):222-7. PubMed ID: 24861503
[TBL] [Abstract][Full Text] [Related]
22. 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome.
Yun KH; Oh SK; Rhee SJ; Yoo NJ; Kim NH; Jeong JW
Int J Cardiol; 2011 Jan; 146(1):68-72. PubMed ID: 20471117
[TBL] [Abstract][Full Text] [Related]
23. Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
Zhang J; Li Y; Tao GZ; Chen YD; Hu TH; Cao XB; Jing QM; Wang XZ; Ma YY; Wang G; Liu HW; Wang B; Xu K; Li J; Deng J; Han YL
Chin Med J (Engl); 2015 Mar; 128(6):784-9. PubMed ID: 25758273
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study).
Ko YG; Won H; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Bae JH; Lee S; Lim DS; Jang Y
Am J Cardiol; 2014 Jul; 114(1):29-35. PubMed ID: 24831577
[TBL] [Abstract][Full Text] [Related]
25. ACP Journal Club: review: statins before coronary catheterization reduce contrast-induced acute kidney injury.
Aggarwal H; Brott BC
Ann Intern Med; 2014 Nov; 161(10):JC7. PubMed ID: 25402540
[No Abstract] [Full Text] [Related]
26. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
[TBL] [Abstract][Full Text] [Related]
27. [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].
Kuznetsova MA; Vaulin NA; Masenko VP; Gratsianskiĭ NA
Kardiologiia; 2010; 50(2):21-5. PubMed ID: 20146674
[TBL] [Abstract][Full Text] [Related]
28. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
Kocas C; Yildiz A; Abaci O; Karaca OS; Firdin N; Dalgic Y; Bostan C; Ersanli M
Angiology; 2015 Nov; 66(10):964-8. PubMed ID: 25852211
[TBL] [Abstract][Full Text] [Related]
29. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
[TBL] [Abstract][Full Text] [Related]
31. Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).
Pitt B; Loscalzo J; Monyak J; Miller E; Raichlen J
Am J Cardiol; 2012 May; 109(9):1239-46. PubMed ID: 22360820
[TBL] [Abstract][Full Text] [Related]
32. By the way, doctor. I take a fiber supplement, but have heard that I shouldn't be taking it at the same times as medication. How far apart should I take fiber and medicines such as Plavix and Crestor?
Gharib S
Harv Health Lett; 2010 May; 35(7):3. PubMed ID: 20589954
[No Abstract] [Full Text] [Related]
33. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M;
Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692
[TBL] [Abstract][Full Text] [Related]
34. Statins and contrast-induced acute kidney injury with coronary angiography.
Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
[TBL] [Abstract][Full Text] [Related]
35. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.
Ballantyne CM; Raichlen JS; Nicholls SJ; Erbel R; Tardif JC; Brener SJ; Cain VA; Nissen SE;
Circulation; 2008 May; 117(19):2458-66. PubMed ID: 18378607
[TBL] [Abstract][Full Text] [Related]
36. Change in near-infrared spectroscopy of a coronary artery after 1-year treatment with high dose rosuvastatin.
Simsek C; van Geuns RJ; Magro M; Boersma E; Garcia-Garcia HM; Serruys PW
Int J Cardiol; 2012 Jun; 157(3):e54-6. PubMed ID: 22000422
[No Abstract] [Full Text] [Related]
37. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial.
Tropeano F; Leoncini M; Toso A; Maioli M; Dabizzi L; Biagini D; Villani S; Bellandi F
J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):159-66. PubMed ID: 26307206
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome.
Celik IE; Kurtul A; Duran M; Yarlioglues M; Elcik D; Kilic A; Koseoglu C; Oksuz F; Murat SN
Coron Artery Dis; 2016 Jan; 27(1):13-8. PubMed ID: 26267748
[TBL] [Abstract][Full Text] [Related]
39. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.
Murat SN; Kurtul A; Yarlioglues M
Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.
Lablanche JM; Leone A; Merkely B; Morais J; Alonso J; Santini M; Eha J; Demil N; Licour M; Tardif JC;
Arch Cardiovasc Dis; 2010 Mar; 103(3):160-9. PubMed ID: 20417447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
